Enhancing Intervention for Residual Rhotic Errors Via App-Delivered Biofeedback: A Case Study

J Speech Lang Hear Res. 2017 Jun 22;60(6S):1810-1817. doi: 10.1044/2017_JSLHR-S-16-0248.

Abstract

Purpose: Recent research suggests that visual-acoustic biofeedback can be an effective treatment for residual speech errors, but adoption remains limited due to barriers including high cost and lack of familiarity with the technology. This case study reports results from the first participant to complete a course of visual-acoustic biofeedback using a not-for-profit iOS app, Speech Therapist's App for /r/ Treatment.

Method: App-based biofeedback treatment for rhotic misarticulation was provided in weekly 30-min sessions for 20 weeks. Within-treatment progress was documented using clinician perceptual ratings and acoustic measures. Generalization gains were assessed using acoustic measures of word probes elicited during baseline, treatment, and maintenance sessions.

Results: Both clinician ratings and acoustic measures indicated that the participant significantly improved her rhotic production accuracy in trials elicited during treatment sessions. However, these gains did not transfer to generalization probes.

Conclusions: This study provides a proof-of-concept demonstration that app-based biofeedback is a viable alternative to costlier dedicated systems. Generalization of gains to contexts without biofeedback remains a challenge that requires further study. App-delivered biofeedback could enable clinician-research partnerships that would strengthen the evidence base while providing enhanced treatment for children with residual rhotic errors.

Supplemental material: https://doi.org/10.23641/asha.5116318.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Articulation Disorders / therapy*
  • Biofeedback, Psychology* / methods
  • Female
  • Generalization, Psychological
  • Humans
  • Mobile Applications*
  • Phonetics
  • Proof of Concept Study
  • Speech Acoustics
  • Speech Therapy* / methods
  • Therapy, Computer-Assisted*
  • Treatment Outcome